OpenAlex
PricingAboutJobs
Log inGet started
Work

Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma: How Different are these From Conventional Treatment Responses?

HTML

Year: 2011
Type: review
Source: American Journal of Clinical Oncology
DOI: 10.1097/coc.0b013e318209cda9
Authors: Gregory K. Pennock, William Waterfield, Jedd D. Wolchok
Institutions: MedStar Franklin Square Medical Center, Memorial Sloan Kettering Cancer Center
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ipilimumab, metastatic melanoma, CTLA-4 inhibition, immune checkpoint blockade, tumor response assessment, immune-related response criteria, disease progression, treatment toxicity, chemotherapy comparison, antitumor T-cell responses
SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb
OpenAlex ID: W2038388329
FWCI: 1.11
Cites: 35
Cited by: 91
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security